Royal Bank of Canada’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Sell |
338
-2,220
| -87% | -$190K | ﹤0.01% | 5763 |
|
|
2025
Q1 | $182K | Buy |
2,558
+2,033
| +387% | +$145K | ﹤0.01% | 4425 |
|
|
2024
Q4 | $24K | Sell |
525
-2,120
| -80% | -$96.9K | ﹤0.01% | 5553 |
|
|
2024
Q3 | $133K | Buy |
2,645
+576
| +28% | +$29K | ﹤0.01% | 4710 |
|
|
2024
Q2 | $84K | Buy |
2,069
+1,979
| +2,199% | +$80.3K | ﹤0.01% | 4983 |
|
|
2024
Q1 | $4K | Buy |
+90
| New | +$4K | ﹤0.01% | 6078 |
|
|
2023
Q1 | – | Sell |
-6
| Closed | – | – | 6902 |
|
|
2022
Q4 | $0 | Sell |
6
-3
| -33% | – | ﹤0.01% | 7107 |
|
|
2022
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 7242 |
|
|
2022
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 7111 |
|
|
2022
Q1 | $0 | Sell |
9
-10
| -53% | – | ﹤0.01% | 7386 |
|
|
2021
Q4 | $0 | Hold |
19
| – | – | ﹤0.01% | 7236 |
|
|
2021
Q3 | $0 | Sell |
19
-240
| -93% | – | ﹤0.01% | 7235 |
|
|
2021
Q2 | $4K | Sell |
259
-82
| -24% | -$1.27K | ﹤0.01% | 6622 |
|
|
2021
Q1 | $6K | Buy |
341
+16
| +5% | +$282 | ﹤0.01% | 6498 |
|
|
2020
Q4 | $9K | Buy |
325
+321
| +8,025% | +$8.89K | ﹤0.01% | 5887 |
|
|
2020
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 6333 |
|
|
2020
Q2 | – | Sell |
-36
| Closed | -$1K | – | 6304 |
|
|
2020
Q1 | $1K | Hold |
36
| – | – | ﹤0.01% | 5981 |
|
|
2019
Q4 | $2K | Sell |
36
-2
| -5% | -$111 | ﹤0.01% | 5963 |
|
|
2019
Q3 | $1K | Buy |
38
+37
| +3,700% | +$974 | ﹤0.01% | 5829 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6005 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 5904 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6080 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6246 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6055 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 5941 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 5998 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6093 |
|